Drug
Insulin Infusion
Insulin Infusion is a pharmaceutical drug with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 66.7%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
2(33%)
Results Posted
0%(0 trials)
Terminated
1(17%)
Phase Distribution
Ph not_applicable
5
83%
Ph phase_4
1
17%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution6 total trials
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
5(83.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
2
trials recruiting
Total Trials
6
all time
Status Distribution
Active(3)
Completed(2)
Terminated(1)
Detailed Status
Completed2
Recruiting2
Terminated1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
2
Success Rate
66.7%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (16.7%)
N/A5 (83.3%)
Trials by Status
terminated117%
completed233%
recruiting233%
not_yet_recruiting117%
Recent Activity
2 active trials
Showing 5 of 6
not_yet_recruitingnot_applicable
Postoperative Insulin Intervention After Pancreatectomy in nDM Patients
NCT07540975
recruitingnot_applicable
Physical Activity and Insulin Sensitivity Dynamics
NCT06776094
recruitingnot_applicable
mTOR as Mediator of Insulin Sensitivity Study
NCT05233722
completednot_applicable
The Suppression of Toll Like Receptors by Insulin
NCT01151605
terminatednot_applicable
Insulin Infusion Diabetes Ulcer
NCT00700154
Clinical Trials (6)
Showing 6 of 6 trials
NCT07540975Not Applicable
Postoperative Insulin Intervention After Pancreatectomy in nDM Patients
NCT06776094Not Applicable
Physical Activity and Insulin Sensitivity Dynamics
NCT05233722Not Applicable
mTOR as Mediator of Insulin Sensitivity Study
NCT01151605Not Applicable
The Suppression of Toll Like Receptors by Insulin
NCT00700154Not Applicable
Insulin Infusion Diabetes Ulcer
NCT01504620Phase 4
Performance Evaluation of Blood Glucose Monitoring Systems
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6